At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of focus, smart spending ...
The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...
The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side ...
If confirmed to the role, Robert F. Kennedy Jr. would oversee the country's top health agencies, including the Food and Drug ...
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...
A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback